South Africa Biobank Market Size & Outlook, 2026-2033
Global Market
Related Markets
South Africa biobank market highlights
- The South Africa biobank market generated a revenue of USD 421.3 million in 2025 and is expected to reach USD 691.2 million by 2033.
- The South Africa market is expected to grow at a CAGR of 6.5% from 2026 to 2033.
- In terms of segment, services was the largest revenue generating product & services in 2025.
- Services is the most lucrative product & services segment registering the fastest growth during the forecast period.
Biobank market data book summary
| Market revenue in 2025 | USD 421.3 million |
| Market revenue in 2033 | USD 691.2 million |
| Growth rate | 6.5% (CAGR from 2026 to 2033) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Qiagen NV, Booz Allen Hamilton Holding Corp Class A, Tecan Group AG, Danaher Corp, Becton Dickinson & Co, Taylor-Wharton, Charles River Laboratories International Inc, Lonza Group Ltd, STEMCELL Technologies, PromoCell GmbH |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.5% of the global biobank market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Middle East & Africa, Saudi Arabia biobank market is projected to lead the regional market in terms of revenue in 2033.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 444.6 million by 2033.
South Africa witnesses a high burden of infectious diseases, along with an increasing prevalence of noncommunicable and metabolic diseases. As a result, demand for biobanking operations in the country for facilitating public health development is one of the key drivers for the market.
Furthermore, the country witnesses an increasing need for the development of national human biobanks as evidenced by initiatives, such as the H3Africa consortium. The consortium includes the development of harmonized and standardized operational procedures for biobanking.
Which is expected to attract more biobanking players in the country. However, South Africa faces severe limitations with respect to energy resources and is restrained by consistent power outages that result from the country.
No credit card required*
Publish Date: Dec 16, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Biobank Market Scope
Biobank Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Becton Dickinson & Co | View profile | 73,000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | www.bd.com |
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Charles River Laboratories International Inc | View profile | 21,400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | www.criver.com |
| Tecan Group AG | View profile | 3,591 | Seestrasse 103, Mannedorf, Switzerland, 8708 | www.tecan.com |
| PromoCell GmbH | View profile | 51-100 | Heidelberg, Baden-Wurttemberg, Germany, Europe | www.promocell.com/ |
| Taylor-Wharton | View profile | 251-500 | Baytown, Texas, United States, North America | twcryo.com |
South Africa Biobank Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biobank Market Outlook will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 87.11% in 2025.
Horizon Databook has segmented the South Africa biobank market based on product, services covering the revenue growth of each sub-segment from 2021 to 2033.
South Africa witnesses a high burden of infectious diseases, along with an increasing prevalence of noncommunicable and metabolic diseases. As a result, demand for biobanking operations in the country for facilitating public health development is one of the key drivers for the market.
Furthermore, the country witnesses an increasing need for the development of national human biobanks as evidenced by initiatives, such as the H3Africa consortium. The consortium includes the development of harmonized and standardized operational procedures for biobanking.
Which is expected to attract more biobanking players in the country. However, South Africa faces severe limitations with respect to energy resources and is restrained by consistent power outages that result from the country.
- South Africa Biobank Market Product & Services Outlook (Revenue, USD Million , 2021-2033)
- Product
- Services
- South Africa Biobank Market Biospecimen Type Outlook (Revenue, USD Million , 2021-2033)
- Human Tissues
- Organs
- Stem Cells
- Other Biospecimens
- South Africa Biobank Market Biobank Type Outlook (Revenue, USD Million , 2021-2033)
- Physical/Real Biobanks
- Virtual Biobanks
- South Africa Biobank Market Application Outlook (Revenue, USD Million , 2021-2033)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
Reasons to subscribe to Biobank Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biobank Market Outlook databook
- Our clientele includes a mix of Biobank Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa Biobank Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into South Africa Biobank Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
South Africa Biobank Market, 2021-2033 (US$M)
South Africa biobank market statistics, by product & services, 2021-2033 (US$M)
